spironolactone has been researched along with empagliflozin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ivkin, D; Karpov, A; Kaschina, E; Krasnova, M; Kulikov, A; Okovityi, S; Smirnov, A | 1 |
| Degerman, E; In 't Zandt, R; Magnusson, M; Pålbrink, AK | 1 |
2 other study(ies) available for spironolactone and empagliflozin
| Article | Year |
|---|---|
Comparative efficacy of empagliflozin and drugs of baseline therapy in post-infarct heart failure in normoglycemic rats.
Topics: Animals; Benzhydryl Compounds; Bisoprolol; Cardiovascular Agents; Chronic Disease; Disease Models, Animal; Exercise Tolerance; Fosinopril; Glucosides; Heart Failure; Male; Myocardial Infarction; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors; Spironolactone; Ventricular Dysfunction, Left; Ventricular Function, Left | 2020 |
Betahistine prevents development of endolymphatic hydrops in a mouse model of insulin resistance and diabetes.
Topics: Animals; Betahistine; Diabetes Mellitus; Endolymphatic Hydrops; Insulin Resistance; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Spironolactone | 2023 |